Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer.
Jacobs MT, Wong P, Zhou AY, Becker-Hapak M, Marin ND, Marsala L, Foster M, Foltz JA, Cubitt CC, Tran J, Russler-Germain DA, Neal C, Kersting-Schadek S, Chang L, Schappe T, Pence P, McClain E, Zevallos JP, Rich JT, Paniello RC, Jackson RS, Pipkorn P, Adkins DR, DeSelm CJ, Berrien-Elliott MM, Puram SV, Fehniger TA.
Jacobs MT, et al. Among authors: puram sv.
Clin Cancer Res. 2023 Oct 13;29(20):4196-4208. doi: 10.1158/1078-0432.CCR-23-0156.
Clin Cancer Res. 2023.
PMID: 37556118
Free PMC article.